DPP-4

  • Compare DPP-4 Products
  • Research Area

DPP-4 Inhibitors (6)

water-soluble

Cat.No. Product Name Information Product Use Citation Customer Product Validation
S4002 Sitagliptin phosphate monohydrate Sitagliptin phosphate monohydrate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
  • Sci Rep, 2013, 3:2104
  • Psychoneuroendocrinology, 2015, 53, 195-206
S3031 Linagliptin Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
S3033 Vildagliptin (LAF-237) Vildagliptin (LAF-237) inhibits DPP−4 with IC50 of 2.3 nM.
  • F1000 Res, 2015, 10.12688/f1000research.2-286.v3. eCollection 2013
  • F1000 Res, 2014, 10.12688/f1000research.2-286.v1#sthash.jy5dbjcX.dpuf
S1540 Saxagliptin Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
S2868 Alogliptin Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.
S7513 Trelagliptin Trelagliptin is a highly selective, long-acting DPP-4 inhibitor. Phase 3.

Hover Mouse over '+' to display IC50

Cat.No. Product Name Solubility (25°C)
Water DMSO Ethanol
S4002 Sitagliptin phosphate monohydrate 41 mg/mL 100 mg/mL <1 mg/mL
S3031 Linagliptin <1 mg/mL 17 mg/mL 1 mg/mL
S3033 Vildagliptin (LAF-237) 60 mg/mL 60 mg/mL 60 mg/mL
S1540 Saxagliptin 63 mg/mL 63 mg/mL 24 mg/mL
S2868 Alogliptin 2 mg/mL 68 mg/mL <1 mg/mL
S7513 Trelagliptin <1 mg/mL 71 mg/mL 3 mg/mL
Tags: DPP-4 inhibition | DPP-4 inhibitor diabetes | DPP-4 enzyme | DPP-4 inhibitors mechanism | DPP-4 drugs | DPP-4 cancer | DPP-4 inhibitors list | DPP-4 activity | DPP-4 inhibitors drugs | DPP-4 inhibitors review | new DPP-4 inhibitor | DPP-4 assay | DPP-4 inhibitors cancer | FDA approved DPP-4 inhibitors
Contact Us